TOMI Environmental Solutions Inc Dossier
Qualitative Analysis
Business overview
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global bacteria decontamination and infectious disease control company. The company provides environmental solutions for indoor surface and air disinfection through the manufacturing, sales, and licensing of its premier Binary Ionization Technology (BIT) platform, marketed under the SteraMist brand. Originally developed under a defense grant in association with DARPA in response to the 2001 anthrax attacks, SteraMist utilizes a low-percentage hydrogen peroxide solution activated by cold plasma to produce a fog of ionized Hydrogen Peroxide (iHP). This technology delivers a validated 6-log reduction (99.9999% kill efficacy) against pathogens, leaving no corrosive residue and breaking down into water vapor and oxygen. TOMI serves a broad spectrum of markets, including hospitals, biosafety labs, pharmaceutical manufacturing, compounding pharmacies, and commercial facilities.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Focusing on expanding the high-margin Binary Ionization Technology (BIT) Solution sales tied to the installed base of SteraMist delivery systems.
Expected impact: Generates predictable, high-margin recurring revenue (historically carrying gross margins above 80%) to offset capital equipment sales volatility.
Developing custom integration projects across SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms for life sciences and medical device manufacturers.
Expected impact: Secures high-value B2B relationships in highly regulated industries where decontamination solutions command premium pricing.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Transformative transaction to diversify TOMI's business by combining its disinfection technology with a domestic platform in lithium and advanced graphite materials.
Terms: Enterprise valuation of Carbonium Core set at $120 million. Consideration consists of TOMI common stock equal to 19.99% of outstanding shares immediately prior to the merger, plus a newly created series of preferred stock.
Enables seamless integration of TOMI's iHP technology into existing enclosure systems, driving the SteraMist Integrated System (SIS) platform strategy forward.
Terms: B2B project-based procurement and integration agreements